TAO WU to Retrospective Studies
This is a "connection" page, showing publications TAO WU has written about Retrospective Studies.
Connection Strength
0.171
-
Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3. J Am Soc Cytopathol. 2019 Jul - Aug; 8(4):206-211.
Score: 0.042
-
Risk factors for anastomotic leak and postoperative morbidity after right hemicolectomy for colon cancer: results from a prospective, multi-centre, snapshot study in China. Br J Surg. 2024 Jan 03; 111(1).
Score: 0.015
-
Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database. Haematologica. 2023 09 01; 108(9):2467-2475.
Score: 0.015
-
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort study. Sci Bull (Beijing). 2023 09 30; 68(18):2106-2114.
Score: 0.015
-
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study. Ann Hematol. 2023 Sep; 102(9):2459-2469.
Score: 0.014
-
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma. Cancer Rep (Hoboken). 2023 05; 6(5):e1800.
Score: 0.014
-
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study. Leukemia. 2021 06; 35(6):1671-1682.
Score: 0.012
-
First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv. 2020 07 14; 4(13):3141-3153.
Score: 0.012
-
Effect of age as a continuous variable on survival outcomes and treatment selection in patients with extranodal nasal-type NK/T-cell lymphoma from the China Lymphoma Collaborative Group (CLCG). Aging (Albany NY). 2019 10 06; 11(19):8463-8473.
Score: 0.011
-
Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG). Leuk Lymphoma. 2019 11; 60(11):2669-2678.
Score: 0.011
-
Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma. JAMA Netw Open. 2019 03 01; 2(3):e190194.
Score: 0.011